12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-12), Nkarta's 12-1 Month Momentum % is 72.22%.
The industry rank for Nkarta's 12-1 Month Momentum % or its related term are showing as below:
NKTX's 12-1 Month Momentum % is ranked better than 90.04% of 1486
companies
in the Biotechnology industry
Industry Median: -22.355
vs NKTX: 72.22
Competitive Comparison of Nkarta's 12-1 Month Momentum %
For the Biotechnology subindustry, Nkarta's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nkarta's 12-1 Month Momentum % Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Nkarta's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Nkarta's 12-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Nkarta 12-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Nkarta's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Nkarta Inc is a biopharmaceutical company engaged in developing engineered natural killer (NK) cells to treat cancer. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of tumor targets, and improve persistence for sustained activity in the body for the treatment of cancer. The Company's operations are based in South San Francisco, California.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
NKTX has been successfully added to your